首页> 美国政府科技报告 >Targeting PRMT5 as a Novel Radiosensitization Approach for Primary and Recurrent Prostate Cancer Treatment. Annual Report August 1, 2014-July 31, 2015.

【24h】

Targeting PRMT5 as a Novel Radiosensitization Approach for Primary and Recurrent Prostate Cancer Treatment. Annual Report August 1, 2014-July 31, 2015.

机译：针对pRmT5作为一种新型放射增敏方法，用于治疗原发性和复发性前列腺癌。年度报告2014年8月1日至2015年7月31日。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hu, C.; Deng, X.; Oh, G.; Wu, Y.; Owens, J.;
展开▼
作者单位

展开▼
年度 2015
页码 1-30
总页数 30
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
专利

1. Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. [J] . Murphy GP, Tjoa BA, Simmons SJ, The Prostate . 1999,第1期

机译：II期前列腺癌疫苗试验：一项研究报告，涉及37位初次治疗后复发的患者。
2. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study [J] . Drummond Frances Josephine, Kinnear Heather, OLeary Eamonn, Journal of cancer survivorship: research and practice . 2015,第2期

机译：前列腺癌幸存者的长期健康相关生活质量因初级治疗而异。 PiCTure（前列腺癌治疗，您的经验）研究的结果
3. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study [J] . Frances Josephine Drummond, Heather Kinnear, Eamonn O’Leary, Journal of Cancer Survivorship . 2015,第2期

机译：前列腺癌幸存者的长期健康相关生活质量因初级治疗而异。 PiCTure（前列腺癌治疗，您的经验）研究的结果
4. Vascular-Targeted Photodynamic of Prostate Cancer Phase with Tookad for Recurrent Prostate Cancer Following Radiation Therapy: Initial Clinical Studies [C] . Robert A. Weersink, Brian C. Wilson, Arjen Bogaards, Photonic Therapeutics and Diagnostics III; Progress in Biomedical Optics and Imaging; vol.8 no.1; Proceedings of SPIE-The International Society for Optical Engineering; vol.6424 . 2007

机译：Tookad用于前列腺癌放疗后复发性前列腺癌的血管靶向光动力学研究：初步临床研究
5. Stimuli-responsive targeted therapeutics for treatment of primary and metastatic prostate cancer. [D] . Peng, Zheng-Hong Joseph. 2014

机译：刺激反应性靶向疗法，用于治疗原发性和转移性前列腺癌。
6. HSR: Health Services Research annual report to our readers and the field, September 1, 1996 through August 31, 1997. [O] . S M Shortell 2012

机译：高铁：1996年9月1日至1997年8月31日面向读者和医疗领域的卫生服务研究年度报告。
7. Annual report to SFC on the findings of Education Scotland evaluative activity in Scotland’s colleges during the period 1 August 2014 – 31 July 2015. [O] . 2015

机译：提交给证监会的年度报告，内容是2014年8月1日至2015年7月31日期间，苏格兰大学的苏格兰教育评估活动的调查结果。
8. Targeting PRMT5 as a Novel Radiosensitization Approach for Primary and Recurrent Prostate Cancer Treatment. [R] . Hu, C., Deng, X., Suarez, C., 2016

机译：针对pRmT5作为一种新型放射增敏方法，用于治疗原发性和复发性前列腺癌。

Targeting PRMT5 as a Novel Radiosensitization Approach for Primary and Recurrent Prostate Cancer Treatment. Annual Report August 1, 2014-July 31, 2015.

著录项

引文网络

相似文献

相关主题

期刊订阅